India Fines GSK, Sanofi $10M For Anti-Competitive Plot
The Competition Commission of India has ordered GlaxoSmithKline Pharmaceuticals Ltd. and Sanofi SA to pay nearly $10 million in fines for colluding in 2011 in their bidding practices for supplying a...To view the full article, register now.
Already a subscriber? Click here to view full article